Skip to main content
Erschienen in: Der Urologe 6/2017

24.05.2017 | Schmerzsyndrome | CME

Interstitielle Zystitis

Diagnostik, medikamentöse und operative Therapie

verfasst von: Dr. A. Gonsior, J. Neuhaus, L. C. Horn, Prof. T. Bschleipfer, J.-U. Stolzenburg

Erschienen in: Die Urologie | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die interstitielle Zystitis/das Blasenschmerzsyndrom (IC/BPS) ist eine chronische Erkrankung mit weitreichenden negativen Auswirkungen auf die Lebensqualität. Eine autoimmungenetische Prädisposition korreliert mit der Theorie der Pathogenese. Die Diagnostik erfordert eine Anamnese, Miktionstagebücher, körperliche und differenzialdiagnostische Untersuchungen, eine Zystoskopie mit oder ohne Hydrodistension und/oder eine Blasenbiopsie. Verschiedene biologische Marker werden getestet, sind aber bisher nicht etabliert. Verhaltensmaßnahmen sowie pharmakologische orale und intravesikale, interventionelle und chirurgische Therapien mit einem breiten Spektrum publizierter Therapieerfolge stehen zur Verfügung. Ein multimodaler Ansatz ist empfehlenswert, den meisten therapeutischen Optionen fehlt es jedoch am „level of evidence“.
Literatur
2.
Zurück zum Zitat Jocham D, Froehlich G, Sandig F et al (2013) The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients (Die Versorgungssituation von Patienten mit interstitieller Zystitis in Deutschland : Ergebnisse einer Umfrage unter 270 Betroffenen). Urologe A 52(5):691–702CrossRefPubMed Jocham D, Froehlich G, Sandig F et al (2013) The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients (Die Versorgungssituation von Patienten mit interstitieller Zystitis in Deutschland : Ergebnisse einer Umfrage unter 270 Betroffenen). Urologe A 52(5):691–702CrossRefPubMed
3.
Zurück zum Zitat Hanno PM, Burks DA, Clemens JQ et al (2011) AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 185(6):2162–2170CrossRefPubMed Hanno PM, Burks DA, Clemens JQ et al (2011) AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 185(6):2162–2170CrossRefPubMed
4.
Zurück zum Zitat Homma Y, Ueda T, Tomoe H et al (2016) Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol 23(7):542–549CrossRefPubMed Homma Y, Ueda T, Tomoe H et al (2016) Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol 23(7):542–549CrossRefPubMed
5.
Zurück zum Zitat Engeler DS, Baranowski AP, Dinis-Oliveira P et al (2013) The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 64(3):431–439CrossRefPubMed Engeler DS, Baranowski AP, Dinis-Oliveira P et al (2013) The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 64(3):431–439CrossRefPubMed
6.
Zurück zum Zitat Fall M, Baranowski AP, Elneil S et al (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57(1):35–48CrossRefPubMed Fall M, Baranowski AP, Elneil S et al (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57(1):35–48CrossRefPubMed
7.
Zurück zum Zitat van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53(1):60–67CrossRefPubMed van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53(1):60–67CrossRefPubMed
8.
Zurück zum Zitat Bschleipfer T, Vahlensieck W, Doggweiler R (2015) Interstitielle Zystitis/Blasenschmerzsyndrom. Urol Scan 02(04):265–278CrossRef Bschleipfer T, Vahlensieck W, Doggweiler R (2015) Interstitielle Zystitis/Blasenschmerzsyndrom. Urol Scan 02(04):265–278CrossRef
10.
Zurück zum Zitat Farmer MA, Chanda ML, Parks EL et al (2011) Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 186(1):117–124CrossRefPubMedPubMedCentral Farmer MA, Chanda ML, Parks EL et al (2011) Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol 186(1):117–124CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Clemens JQ, Meenan RT, Rosetti MCO et al (2005) Prevalence and incidence of interstitial cystitis in a managed care population. J Urol 173(1):98–102CrossRefPubMed Clemens JQ, Meenan RT, Rosetti MCO et al (2005) Prevalence and incidence of interstitial cystitis in a managed care population. J Urol 173(1):98–102CrossRefPubMed
12.
Zurück zum Zitat Curhan GC, Speizer FE, Hunter DJ et al (1999) Epidemiology of interstitial cystitis: a population based study. J Urol 161(2):549–552CrossRefPubMed Curhan GC, Speizer FE, Hunter DJ et al (1999) Epidemiology of interstitial cystitis: a population based study. J Urol 161(2):549–552CrossRefPubMed
13.
Zurück zum Zitat Kusek JW, Nyberg LM (2001) The epidemiology of interstitial cystitis: is it time to expand our definition? Urology 57(6 Suppl 1):95–99CrossRefPubMed Kusek JW, Nyberg LM (2001) The epidemiology of interstitial cystitis: is it time to expand our definition? Urology 57(6 Suppl 1):95–99CrossRefPubMed
14.
Zurück zum Zitat Rosenberg MT, Page S, Hazzard MA (2007) Prevalence of interstitial cystitis in a primary care setting. Urology 69(4 Suppl):48–52CrossRefPubMed Rosenberg MT, Page S, Hazzard MA (2007) Prevalence of interstitial cystitis in a primary care setting. Urology 69(4 Suppl):48–52CrossRefPubMed
15.
Zurück zum Zitat Berry SH, Elliott MN, Suttorp M et al (2011) Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol 186(2):540–544CrossRefPubMedPubMedCentral Berry SH, Elliott MN, Suttorp M et al (2011) Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol 186(2):540–544CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hunner GL (1918) A rare type of bladder ulcer: further notes, with a report of eighteen cases. JAMA 17(70):203–212CrossRef Hunner GL (1918) A rare type of bladder ulcer: further notes, with a report of eighteen cases. JAMA 17(70):203–212CrossRef
17.
Zurück zum Zitat Kuo HC (2014) Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis. Int J Urol 21(Suppl 1):34–41CrossRefPubMed Kuo HC (2014) Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis. Int J Urol 21(Suppl 1):34–41CrossRefPubMed
18.
Zurück zum Zitat Theoharides TC, Alysandratos K‑D, Angelidou A et al (2012) Mast cells and inflammation. Biochim Biophys Acta 1822(1):21–33CrossRefPubMed Theoharides TC, Alysandratos K‑D, Angelidou A et al (2012) Mast cells and inflammation. Biochim Biophys Acta 1822(1):21–33CrossRefPubMed
19.
Zurück zum Zitat Altman D, Lundholm C, Milsom I et al (2011) The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol 59(2):280–285CrossRefPubMed Altman D, Lundholm C, Milsom I et al (2011) The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol 59(2):280–285CrossRefPubMed
20.
Zurück zum Zitat Emmungil H, Kalfa M, Zihni FY et al (2012) Interstitial cystitis: a rare manifestation of primary Sjogren’s syndrome, successfully treated with low dose cyclosporine. Rheumatol Int 32(5):1215–1218CrossRefPubMed Emmungil H, Kalfa M, Zihni FY et al (2012) Interstitial cystitis: a rare manifestation of primary Sjogren’s syndrome, successfully treated with low dose cyclosporine. Rheumatol Int 32(5):1215–1218CrossRefPubMed
21.
Zurück zum Zitat Schwalenberg T, Berger FP, Horn LC et al (2015) Intravesical glycosaminoglycan replacement with chondroitin sulphate (Gepan((R)) instill) in patients with chronic radiotherapy- or chemotherapy-associated cystitis. Clin Drug Investig 35(8):505–512CrossRefPubMedPubMedCentral Schwalenberg T, Berger FP, Horn LC et al (2015) Intravesical glycosaminoglycan replacement with chondroitin sulphate (Gepan((R)) instill) in patients with chronic radiotherapy- or chemotherapy-associated cystitis. Clin Drug Investig 35(8):505–512CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Warren JW, Jackson TL, Langenberg P et al (2004) Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 63(1):17–21CrossRefPubMed Warren JW, Jackson TL, Langenberg P et al (2004) Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 63(1):17–21CrossRefPubMed
23.
Zurück zum Zitat Davis NF, Brady CM, Creagh T (2014) Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol 175:30–37CrossRefPubMed Davis NF, Brady CM, Creagh T (2014) Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol 175:30–37CrossRefPubMed
25.
Zurück zum Zitat Chambers GK, Fenster HN, Cripps S et al (1999) An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol 162(3 Pt 1):699–701CrossRefPubMed Chambers GK, Fenster HN, Cripps S et al (1999) An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol 162(3 Pt 1):699–701CrossRefPubMed
26.
Zurück zum Zitat Jiang Y‑H, Jhang J‑F, Kuo H‑C (2016) Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis. PLOS ONE 11(3):e0151692CrossRefPubMedPubMedCentral Jiang Y‑H, Jhang J‑F, Kuo H‑C (2016) Revisiting the role of potassium sensitivity testing and cystoscopic hydrodistention for the diagnosis of interstitial cystitis. PLOS ONE 11(3):e0151692CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Keay SK, Zhang CO, Shoenfelt J et al (2001) Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57(6 Suppl 1):9–14CrossRefPubMed Keay SK, Zhang CO, Shoenfelt J et al (2001) Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57(6 Suppl 1):9–14CrossRefPubMed
28.
Zurück zum Zitat Baka S, Kouskouni E, Antonopoulou S et al (2009) Prevalence of ureaplasma urealyticum and mycoplasma hominis in women with chronic urinary symptoms. Urology 74(1):62–66CrossRefPubMed Baka S, Kouskouni E, Antonopoulou S et al (2009) Prevalence of ureaplasma urealyticum and mycoplasma hominis in women with chronic urinary symptoms. Urology 74(1):62–66CrossRefPubMed
29.
Zurück zum Zitat Kim H‑J (2016) Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review. Int Neurourol J 20(1):13–17CrossRefPubMedPubMedCentral Kim H‑J (2016) Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review. Int Neurourol J 20(1):13–17CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Regauer S (2016) Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia. Transl Androl Urol 5(3):396–397CrossRefPubMedPubMedCentral Regauer S (2016) Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia. Transl Androl Urol 5(3):396–397CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Gamper M, Regauer S, Welter J et al (2015) Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol 193(6):1994–2000CrossRefPubMed Gamper M, Regauer S, Welter J et al (2015) Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol 193(6):1994–2000CrossRefPubMed
32.
Zurück zum Zitat Tettamanti G, Nyman-Iliadou A, Pedersen NL et al (2011) Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology 77(6):1313–1317CrossRefPubMedPubMedCentral Tettamanti G, Nyman-Iliadou A, Pedersen NL et al (2011) Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology 77(6):1313–1317CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Parsons CL, Koprowski PF (1991) Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 37(3):207–212CrossRefPubMed Parsons CL, Koprowski PF (1991) Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 37(3):207–212CrossRefPubMed
34.
Zurück zum Zitat Hill JR, Isom-Batz G, Panagopoulos G et al (2008) Patient perceived outcomes of treatments used for interstitial cystitis. Urology 71(1):62–66CrossRefPubMed Hill JR, Isom-Batz G, Panagopoulos G et al (2008) Patient perceived outcomes of treatments used for interstitial cystitis. Urology 71(1):62–66CrossRefPubMed
35.
Zurück zum Zitat Nickel JC, Herschorn S, Whitmore KE et al (2015) Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol 193(3):857–862CrossRefPubMed Nickel JC, Herschorn S, Whitmore KE et al (2015) Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol 193(3):857–862CrossRefPubMed
36.
Zurück zum Zitat Nickel JC, Barkin J, Forrest J et al (2005) Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 65(4):654–658CrossRefPubMed Nickel JC, Barkin J, Forrest J et al (2005) Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 65(4):654–658CrossRefPubMed
37.
Zurück zum Zitat Cervigni M (2015) Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy. Transl Androl Urol 4(6):638–642PubMedPubMedCentral Cervigni M (2015) Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy. Transl Androl Urol 4(6):638–642PubMedPubMedCentral
38.
Zurück zum Zitat Moldwin RM, Evans RJ, Stanford EJ et al (2007) Rational approaches to the treatment of patients with interstitial cystitis. Urology 69(4 Suppl):73–81CrossRefPubMed Moldwin RM, Evans RJ, Stanford EJ et al (2007) Rational approaches to the treatment of patients with interstitial cystitis. Urology 69(4 Suppl):73–81CrossRefPubMed
39.
Zurück zum Zitat Davis EL, El Khoudary SR, Talbott EO et al (2008) Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179(1):177–185CrossRefPubMed Davis EL, El Khoudary SR, Talbott EO et al (2008) Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 179(1):177–185CrossRefPubMed
40.
Zurück zum Zitat van Ophoven A, Hertle L (2005) Long-term results of amitriptyline treatment for interstitial cystitis. J Urol 174(5):1837–1840CrossRefPubMed van Ophoven A, Hertle L (2005) Long-term results of amitriptyline treatment for interstitial cystitis. J Urol 174(5):1837–1840CrossRefPubMed
41.
Zurück zum Zitat Chen H, Wang F, Chen W et al (2014) Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial – treatment of interstitial cystitis/painful bladder syndrome with low-dose sildenafil. Urology 84(1):51–56CrossRefPubMed Chen H, Wang F, Chen W et al (2014) Efficacy of daily low-dose sildenafil for treating interstitial cystitis: results of a randomized, double-blind, placebo-controlled trial – treatment of interstitial cystitis/painful bladder syndrome with low-dose sildenafil. Urology 84(1):51–56CrossRefPubMed
42.
Zurück zum Zitat Sairanen J, Tammela TLJ, Leppilahti M et al (2005) Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 174(6):2235–2238CrossRefPubMed Sairanen J, Tammela TLJ, Leppilahti M et al (2005) Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 174(6):2235–2238CrossRefPubMed
43.
Zurück zum Zitat Nickel JC, Egerdie RB, Steinhoff G et al (2010) A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. Urology 76(4):804–809CrossRefPubMed Nickel JC, Egerdie RB, Steinhoff G et al (2010) A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. Urology 76(4):804–809CrossRefPubMed
44.
Zurück zum Zitat Parsons CL, Koziol JA, Proctor JG et al (2015) Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol 22(2):7739–7744PubMed Parsons CL, Koziol JA, Proctor JG et al (2015) Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms. Can J Urol 22(2):7739–7744PubMed
45.
Zurück zum Zitat Henry RA, Morales A, Cahill CM (2015) Beyond a simple anesthetic effect: Lidocaine in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Urology 85(5):1025–1033CrossRefPubMed Henry RA, Morales A, Cahill CM (2015) Beyond a simple anesthetic effect: Lidocaine in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Urology 85(5):1025–1033CrossRefPubMed
46.
Zurück zum Zitat Nomiya A, Naruse T, Niimi A et al (2013) On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol 20(11):1118–1122CrossRefPubMed Nomiya A, Naruse T, Niimi A et al (2013) On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol 20(11):1118–1122CrossRefPubMed
47.
Zurück zum Zitat Downey A (2015) Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome. Ulster Med J 84(3):161–163PubMedPubMedCentral Downey A (2015) Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome. Ulster Med J 84(3):161–163PubMedPubMedCentral
48.
Zurück zum Zitat Tomoe H (2015) In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective? Transl Androl Urol 4(6):600–604PubMedPubMedCentral Tomoe H (2015) In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective? Transl Androl Urol 4(6):600–604PubMedPubMedCentral
49.
Zurück zum Zitat Cervigni M, Sommariva M, Tenaglia R et al (2016) A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. doi:10.1002/nau.23091 Cervigni M, Sommariva M, Tenaglia R et al (2016) A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. doi:10.​1002/​nau.​23091
50.
Zurück zum Zitat Payne CK, Mosbaugh PG, Forrest JB et al (2005) Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173(5):1590–1594CrossRefPubMed Payne CK, Mosbaugh PG, Forrest JB et al (2005) Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173(5):1590–1594CrossRefPubMed
51.
Zurück zum Zitat Neuhaus J, Schwalenberg T (2012) Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol 9(12):707–720CrossRefPubMed Neuhaus J, Schwalenberg T (2012) Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol 9(12):707–720CrossRefPubMed
52.
Zurück zum Zitat van Ophoven A, Rossbach G, Pajonk F et al (2006) Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J Urol 176(4 Pt 1):1442–1446CrossRefPubMed van Ophoven A, Rossbach G, Pajonk F et al (2006) Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J Urol 176(4 Pt 1):1442–1446CrossRefPubMed
53.
Zurück zum Zitat Lucioni A, Bales GT, Lotan TL et al (2008) Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 101(3):366–370CrossRefPubMed Lucioni A, Bales GT, Lotan TL et al (2008) Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 101(3):366–370CrossRefPubMed
54.
Zurück zum Zitat Meng J, Wang J, Lawrence G et al (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120(Pt 16):2864–2874CrossRefPubMed Meng J, Wang J, Lawrence G et al (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120(Pt 16):2864–2874CrossRefPubMed
55.
Zurück zum Zitat Chuang Y‑C, Yoshimura N, Huang C‑C et al (2009) Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol 56(1):159–166CrossRefPubMed Chuang Y‑C, Yoshimura N, Huang C‑C et al (2009) Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol 56(1):159–166CrossRefPubMed
56.
Zurück zum Zitat Jhang J‑F, Kuo H‑C (2016) Botulinum toxin A and lower urinary tract dysfunction: pathophysiology and mechanisms of action. Toxins (Basel) 8(4):120CrossRef Jhang J‑F, Kuo H‑C (2016) Botulinum toxin A and lower urinary tract dysfunction: pathophysiology and mechanisms of action. Toxins (Basel) 8(4):120CrossRef
57.
Zurück zum Zitat Kuo H‑C, Jiang Y‑H, Tsai Y‑C et al (2016) Intravesical botulinum toxin – A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment – A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn 35(5):609–614CrossRefPubMed Kuo H‑C, Jiang Y‑H, Tsai Y‑C et al (2016) Intravesical botulinum toxin – A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment – A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn 35(5):609–614CrossRefPubMed
58.
Zurück zum Zitat Lee C‑L, Kuo H‑C (2013) Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician 16(2):109–116PubMed Lee C‑L, Kuo H‑C (2013) Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician 16(2):109–116PubMed
59.
Zurück zum Zitat Steinberg AC, Oyama IA, Whitmore KE (2007) Bilateral S3 stimulator in patients with interstitial cystitis. Urology 69(3):441–443CrossRefPubMed Steinberg AC, Oyama IA, Whitmore KE (2007) Bilateral S3 stimulator in patients with interstitial cystitis. Urology 69(3):441–443CrossRefPubMed
60.
Zurück zum Zitat Whitmore KE, Payne CK, Diokno AC et al (2003) Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct 14(5):305–309CrossRefPubMed Whitmore KE, Payne CK, Diokno AC et al (2003) Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct 14(5):305–309CrossRefPubMed
61.
Zurück zum Zitat Marinkovic SP, Gillen LM, Marinkovic CM (2011) Minimum 6‑year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J 22(4):407–412CrossRefPubMed Marinkovic SP, Gillen LM, Marinkovic CM (2011) Minimum 6‑year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J 22(4):407–412CrossRefPubMed
62.
Zurück zum Zitat Powell CR, Kreder KJ (2010) Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 183(1):173–176CrossRefPubMed Powell CR, Kreder KJ (2010) Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 183(1):173–176CrossRefPubMed
63.
Zurück zum Zitat Payne RA, O’Connor RC, Kressin M et al (2009) Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J 3(6):473–477CrossRefPubMedPubMedCentral Payne RA, O’Connor RC, Kressin M et al (2009) Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J 3(6):473–477CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Linn J, Hohenfellner M, Roth S et al (1998) Treatment of interstitial cystitis. Comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol 159(3):774–778CrossRefPubMed Linn J, Hohenfellner M, Roth S et al (1998) Treatment of interstitial cystitis. Comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol 159(3):774–778CrossRefPubMed
65.
Zurück zum Zitat Peeker R, Aldenborg F, Fall M (1998) The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol 159(5):1479–1482CrossRefPubMed Peeker R, Aldenborg F, Fall M (1998) The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol 159(5):1479–1482CrossRefPubMed
67.
Zurück zum Zitat van Ophoven A, Oberpenning F, Hertle L (2002) Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J Urol 167(2 Pt 1):603–607CrossRefPubMed van Ophoven A, Oberpenning F, Hertle L (2002) Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J Urol 167(2 Pt 1):603–607CrossRefPubMed
68.
Zurück zum Zitat Kochakarn W, Lertsithichai P, Pummangura W (2007) Bladder substitution by ileal neobladder for women with interstitial cystitis. Int Braz J Urol 33(4):486–492CrossRefPubMed Kochakarn W, Lertsithichai P, Pummangura W (2007) Bladder substitution by ileal neobladder for women with interstitial cystitis. Int Braz J Urol 33(4):486–492CrossRefPubMed
69.
Zurück zum Zitat Kim HJ, Lee JS, Cho WJ et al (2014) Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner’s lesion. Int J Urol 21(Suppl 1):69–73CrossRefPubMed Kim HJ, Lee JS, Cho WJ et al (2014) Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner’s lesion. Int J Urol 21(Suppl 1):69–73CrossRefPubMed
70.
71.
Zurück zum Zitat Peters KM, Hasenau D, Killinger KA et al (2014) Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation. Int Urol Nephrol 46(12):2291–2295CrossRefPubMedPubMedCentral Peters KM, Hasenau D, Killinger KA et al (2014) Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation. Int Urol Nephrol 46(12):2291–2295CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Kim A, Shin D‑M, Choo M‑S (2016) Stem cell therapy for interstitial cystitis/bladder pain syndrome. Curr Urol Rep 17(1):1CrossRefPubMed Kim A, Shin D‑M, Choo M‑S (2016) Stem cell therapy for interstitial cystitis/bladder pain syndrome. Curr Urol Rep 17(1):1CrossRefPubMed
73.
Zurück zum Zitat Neuhaus J, Schulte-Baukloh H, Stolzenburg J‑U et al (2012) Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol 30(5):693–700CrossRefPubMed Neuhaus J, Schulte-Baukloh H, Stolzenburg J‑U et al (2012) Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol 30(5):693–700CrossRefPubMed
Metadaten
Titel
Interstitielle Zystitis
Diagnostik, medikamentöse und operative Therapie
verfasst von
Dr. A. Gonsior
J. Neuhaus
L. C. Horn
Prof. T. Bschleipfer
J.-U. Stolzenburg
Publikationsdatum
24.05.2017
Verlag
Springer Medizin
Erschienen in
Die Urologie / Ausgabe 6/2017
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-017-0408-2

Weitere Artikel der Ausgabe 6/2017

Der Urologe 6/2017 Zur Ausgabe

URO-Telegramm

URO-Telegramm

BDU Journal – Berufspolitik

BDU Journal – Berufspolitik